IL1A and Stroke: There is extensive experimental evidence showing that blockade of IL-1 signalling using the IL-1 receptor antagonist (IL-1Ra) is protective in stroke and other forms of brain injury, and early stage clinical trials of IL-1Ra in both ischaemic and haemorrhagic stroke have to date shown potentially promising results (Sobowale et al., 2016).